As we are aware the majority of EU approved API manufacturing sites are located in the Eastern side of China areas include Zhejiang, Hubei, Hebei, Shandong and Jiangsu. While API manufacturing also occurs in other regions these regions are the main ones with Zhejiang being the main source (according to published data on EU certified database). It is reasonable that API’s would be exported from Shanghai Ports to travel onto manufacturing locations in other regions such as India and Europe.

CheckMed is focusing on these products to try to determine if this will affect the medicine supply of products which API originates from this region. We understand manufacturing companies typically hold 4 months of API inventory so the effect on the market will be further down the track.

Many critical medicines have only single API’s which has resulted in market forces causing this to occur.